Pulse Biosciences (PLSE) Receivables (2021 - 2026)

Pulse Biosciences has reported Receivables for 5 years, with the latest figure at $122000.0 in Q2 2026.

• On a quarterly basis, Receivables changed N/A year-over-year to $122000.0 in Q2 2026; TTM through Jun 2026 was $122000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $274000.0, down 77.09% from the prior year.
• Receivables was $122000.0 for Q2 2026 at Pulse Biosciences, down from $274000.0 in the prior quarter.
• The five-year high for Receivables was $274000.0 in Q4 2025, with the low at -$41000.0 in Q4 2024.
• Average Receivables over 4 years is $55625.0, with a median of $21500.0 recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Receivables slumped 130.77% in 2022, then jumped 768.29% in 2025.
• Over 4 years, Receivables stood at -$12000.0 in 2022, then plunged by 241.67% to -$41000.0 in 2024, then soared by 768.29% to $274000.0 in 2025, then plunged by 55.47% to $122000.0 in 2026.
• The last three Receivables figures came in at $122000.0 (Q2 2026), $274000.0 (Q4 2025), and $15000.0 (Q3 2025), per Business Quant data.